ACH-4471 in trials for PNH treatment

		Marrowforums > Treatments > Clinical Trials
ACH-4471 in trials for PNH treatment

Clinical Trials Considering or participating in research studies

Thu Mar 29, 2018, 02:23 PM

Marrowforums Marrowforums is offline

Marrowforums.org

Join Date: Jul 2006

Posts: 920

ACH-4471 in trials for PNH treatment

Achillion Pharmaceuticals is sponsoring a tiny Phase II trial of ACH-4471, a new drug for the treatment of PNH.

ACH-4471 inhibits a specific molecule that is part of the complement process, and may reduce hemolysis.

ACH-4471 was recently approved in Europe for treatment of C3 glomerulopathy.

Thread Tools	Search this Thread
Show Printable Version Email this Page	Search this Thread: Advanced Search

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts vB code is On Smilies are On [IMG] code is On HTML code is Off

Forum Jump

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Learning About Clinical Trials and Finding Clinical Trials	Marrowforums	Clinical Trials	0	Wed Jun 3, 2015 06:10 PM
Need help with RCMD treatment (trials)	Mantist	Drugs and Drug Treatments	9	Sun Nov 17, 2013 03:08 AM
New Treatment Center Information	Marrowforums	Site Announcements	0	Sun Feb 17, 2008 05:53 PM
Interactive Treatment Center Map	Marrowforums	Site Announcements	0	Wed Jan 2, 2008 12:22 AM

All times are GMT -4. The time now is 06:55 AM.